Biosimilar Newsletter Archive
-
04.03.25 -- Optimize Downstream Separation With Tagless Proteins
4/3/2025
04/03/25 Biosimilar Development Newsletter
-
03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development
3/27/2025
03/27/25 Biosimilar Development Newsletter
-
03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture
3/20/2025
03/20/25 Biosimilar Development Newsletter
-
03.20.25 -- Comparison Of WFI Production Methods
3/20/2025
03/20/25 Biosimilar Development Newsletter
-
03.13.25 -- Optimize Your High Concentration Biologic Production Process
3/13/2025
03/13/25 Biosimilar Development Newsletter
-
03.13.25 -- Emerging Trends In mAbs Manufacturing
3/13/2025
03/13/25 Biosimilar Development Newsletter
-
03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars
3/6/2025
03/06/25 Biosimilar Development Newsletter
-
02.27.25 -- A New Approach For Minimizing Human Errors In Biopharmaceuticals
2/27/2025
02/27/25 Biosimilar Development Newsletter
-
02.20.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline
2/20/2025
02/20/25 Biosimilar Development Newsletter
-
02.13.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline
2/13/2025
02/13/25 Biosimilar Development Newsletter